Look for any podcast host, guest or anyone
Showing episodes and shows of

Michael Blaiss

Shows

allergytalkallergytalkUnderstanding the FDA Warning on Cetirizine/LevocetirizineWelcome to a special episode of AllergyTalk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma & Immunology! On May 16, 2025, the FDA issued an alert regarding a rare but serious side effect of severe pruritus after discontinuing long-term use of cetirizine and levocetirizine. In this episode, we’ll discuss the background of this important announcement and what it means for our patients! We are joined by Michael S. Blaiss, MD, clinical professor of pediatrics at the Medical College of Georgia and past-president and former Executive Medical Di...2025-06-0927 minCCO Medical Specialties PodcastCCO Medical Specialties PodcastConversations in Chronic Cough: An Allergist’s PerspectiveListen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough.PresenterMichael S. Blaiss, MDClinical Professor of PediatricsDivision of Allergy-ImmunologyMedical College of Georgia at Augusta UniversityAugusta, GeorgiaLink to full program: https://bit.ly/4kweynG 2025-05-2816 minThe Itch: Allergies, Asthma, Eczema & ImmunologyThe Itch: Allergies, Asthma, Eczema & Immunology#109 - Tezepelumab & Nasal Polyps: Inside the WAYPOINT Phase III TrialHave you wondered why having more drug options matters for chronic rhinosinusitis with nasal polyps? In the inaugural episode of our new series, The Itch Review, co-hosts Kortney and Dr. Payel Gupta, along with special guest Dr. Michael Blaiss, unpack the journal article "Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps," published in the New England Journal of Medicine on March 1, 2025. This article is about the Phase III WAYPOINT trial of tezepelumab. Already approved for severe asthma, this once-monthly biologic is now showing promise in chronic rhinosinusitis with nasal polyps (CRSwNP). Over 52 weeks, 408...2025-04-2427 minThe Itch: Allergies, Asthma, Eczema & ImmunologyThe Itch: Allergies, Asthma, Eczema & Immunology#109 - Tezepelumab & Nasal Polyps: Inside the WAYPOINT Phase III TrialHave you wondered why having more drug options matters for chronic rhinosinusitis with nasal polyps? In the inaugural episode of our new series, The Itch Review, co-hosts Kortney and Dr. Payel Gupta, along with special guest Dr. Michael Blaiss, unpack the journal article "Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps," published in the New England Journal of Medicine on March 1, 2025. This article is about the Phase III WAYPOINT trial of tezepelumab. Already approved for severe asthma, this once-monthly biologic is now showing promise in chronic rhinosinusitis with nasal polyps (CRSwNP). Over 52 weeks, 408...2025-04-2427 minThe Itch: Allergies, Asthma, Eczema & ImmunologyThe Itch: Allergies, Asthma, Eczema & Immunology#102 - Comorbidities of Type 2 InflammationWhy do conditions like asthma, nasal polyps, or eczema become more severe when they coexist? Kortney and Dr. Payel Gupta are joined by Dr. Michael Blaiss to explore the common thread linking multiple allergic and inflammatory diseases: Type 2 Inflammation. If you’ve ever wondered why certain conditions often appear together, this deep dive will help you connect the dots. Type 2 Inflammation is a hot topic in immunology because it’s the engine that drives many allergic and inflammatory diseases. It’s also the key to modern treatment strategies, including targeted biologic therapies. Dr. Blaiss explains how clinicians recogn...2025-02-2126 minThe Itch: Allergies, Asthma, Eczema & ImmunologyThe Itch: Allergies, Asthma, Eczema & Immunology#102 - Comorbidities of Type 2 InflammationWhy do conditions like asthma, nasal polyps, or eczema become more severe when they coexist? Kortney and Dr. Payel Gupta are joined by Dr. Michael Blaiss to explore the common thread linking multiple allergic and inflammatory diseases: Type 2 Inflammation. If you’ve ever wondered why certain conditions often appear together, this deep dive will help you connect the dots. Type 2 Inflammation is a hot topic in immunology because it’s the engine that drives many allergic and inflammatory diseases. It’s also the key to modern treatment strategies, including targeted biologic therapies. Dr. Blaiss explains how clinicians recogn...2025-02-2126 minPodcasts360Podcasts360Management of Patients With Asthma: Critical Observations in Pulmonary Medicine, Ep. 6In this episode, Albert Rizzo, MD, interviews Michael S. Blaiss, MD, to discuss allergic asthma and its comorbidities, including the definition, diagnosis, and management of patients with allergic asthma. They discussed the role of immunotherapy, inhaled steroids, biologics, and bronchial thermoplasty.2022-07-0727 minMedEdTalks - Primary CareMedEdTalks - Primary CareEmerging Options for Refractory Chronic CoughThe diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. Peter Dicpinigaitis discuss emerging therapeutic options for the management of patients with refractory chronic cough.2019-12-1007 minMedEdTalks - Primary CareMedEdTalks - Primary CareChronic Cough – A Typical Patient JourneyThe diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. John Russell and Dr. Michael Blaiss discuss the initial steps for the evaluation and management of patients presenting with chronic cough.2019-12-1010 minMedEdTalks - Primary CareMedEdTalks - Primary CareChronic Cough – Symptoms and BurdenThe diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. John Russell define chronic cough, discuss its symptoms, and review the associated physical and psychological burden of patients with this condition.2019-12-1008 minHot Topics in AllergyHot Topics in AllergyAllergic Rhinitis and Sleep DisordersGuest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.2007-05-2100 minSleep MedicineSleep MedicineAllergic Rhinitis and Sleep Disorders Guest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.2007-05-2100 minAllergy and Clinical ImmunologyAllergy and Clinical ImmunologyAllergic Rhinitis and Sleep Disorders Guest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.2007-05-2100 minAllergy and Clinical ImmunologyAllergy and Clinical ImmunologyAllergic Rhinitis and Sleep Disorders Guest: Michael Blaiss, MD Host: Todd Mahr, MD Dr. Mahr and Dr. Blaiss discuss a recent article published in the Annals of Allergy, Asthma and Immunology focusing on allergic rhinitis and sleep disorders.2007-05-2100 min